MILLENNIUM MANAGEMENT LLC - BIONDVAX PHARMACEUTICALS LTD ownership

BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 13 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of BIONDVAX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2022$9,000
-73.5%
12,275
-39.3%
0.00%
Q1 2022$34,000
+3.0%
20,217
+74.9%
0.00%
Q2 2021$33,00011,5570.00%
Other shareholders
BIONDVAX PHARMACEUTICALS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Vantage Investment Advisors, LLC 17,000$99,0000.03%
Edge Wealth Management LLC 10,000$2,0000.00%
Citadel Advisors 30,583$177,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,236$83,0000.00%
Tower Research Capital LLC (TRC) 100$1,0000.00%
DEUTSCHE BANK AG\ 900$5,0000.00%
BANK OF AMERICA CORP /DE/ 23$00.00%
View complete list of BIONDVAX PHARMACEUTICALS LTD shareholders